​
​

Biora Therapeutics (BIOR) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChartTranscripts

Biora Therapeutics Revenue Highlights

Latest Revenue (Y)

$4.00K

Latest Revenue (Q)

$32.00K

Main Segment (Y)

Commercial Third Party Payors

Main Geography (Y)

Commercial Third Party Payors

Biora Therapeutics Revenue by Period

Biora Therapeutics Revenue by Year

DateRevenueChange
2023-12-31$4.00K-98.69%
2022-12-31$305.00K-75.54%
2021-12-31$1.25M-98.32%
2020-12-31$74.31M-48.39%
2019-12-31$143.99M12.51%
2018-12-31$127.97M-

Biora Therapeutics generated $4.00K in revenue during NA 2023, up -98.69% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Biora Therapeutics Revenue by Quarter

DateRevenueChange
2024-09-30$32.00K-89.94%
2024-06-30$318.00K-41.33%
2024-03-31$542.00K-37.84%
2023-12-31$872.00K100.00%
2023-09-30--100.00%
2023-06-30$2.00K-
2023-03-31$2.00K-85.71%
2022-12-31$14.00K-82.50%
2022-09-30$80.00K-23.08%
2022-06-30$104.00K-2.80%
2022-03-31$107.00K-75.40%
2021-12-31$435.00K139.01%
2021-09-30$182.00K-60.69%
2021-06-30$463.00K-98.11%
2021-03-31$24.53M71.80%
2020-12-31$14.28M-44.97%
2020-09-30$25.94M50.25%
2020-06-30$17.27M2.60%
2020-03-31$16.83M-17.82%
2019-12-31$20.48M9.08%
2019-09-30$18.77M-67.20%
2019-06-30$57.23M20.47%
2019-03-31$47.51M-1286.19%
2018-12-31$-4.00M-

Biora Therapeutics generated $32.00K in revenue during Q3 2024, up -89.94% compared to the previous quarter, and up 1600.00% compared to the same period a year ago.

Biora Therapeutics Revenue Breakdown

Biora Therapeutics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 21Dec 20
Commercial Third Party Payors$42.10M$64.43M
Patient Laboratory Distribution Partners$4.42M$7.15M
Government Health Benefit Programs$14.09M$2.73M

Biora Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 21: Commercial Third Party Payors (69.46%), Government Health Benefit Programs (23.24%), and Patient Laboratory Distribution Partners (7.30%).

Quarterly Revenue by Product

Product/ServiceDec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20
Government Health Benefit Programs$2.02M$1.62M$4.72M$5.73M$6.11M$5.69M$-2.92M
Patient Laboratory Distribution Partners$436.00K$701.00K$936.00K$2.35M$1.89M$1.70M$2.16M
Commercial Third Party Payors$5.20M$7.40M$13.04M$16.45M$6.29M$18.55M$18.03M

Biora Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Dec 21: Commercial Third Party Payors (67.94%), Government Health Benefit Programs (26.37%), and Patient Laboratory Distribution Partners (5.69%).

Biora Therapeutics Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 21Dec 20
Commercial Third Party Payors$42.10M$64.43M
Patient Laboratory Distribution Partners$4.42M$7.15M
Government Health Benefit Programs$14.09M$2.73M

Biora Therapeutics's latest annual revenue breakdown by geography, as of Dec 21: Commercial Third Party Payors (69.46%), Government Health Benefit Programs (23.24%), and Patient Laboratory Distribution Partners (7.30%).

Quarterly Revenue by Country

CountryDec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20
Commercial Third Party Payors$5.20M$7.40M$13.04M$16.45M$6.29M$18.55M$18.03M
Patient Laboratory Distribution Partners$436.00K$701.00K$936.00K$2.35M$1.89M$1.70M$2.16M
Government Health Benefit Programs$2.02M$1.62M$4.72M$5.73M$6.11M$5.69M$-2.92M

Biora Therapeutics's latest quarterly revenue breakdown by geography, as of Dec 21: Commercial Third Party Payors (67.94%), Government Health Benefit Programs (26.37%), and Patient Laboratory Distribution Partners (5.69%).

Biora Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
BIORBiora Therapeutics$4.00K$32.00K
CWBRCohBar--
AVROAVROBIO--
ZURAZura Bio--
ELEVElevation Oncology--
ZVSAZyVersa Therapeutics--
OCEAOcean Biomedical--
HEPAHepion Pharmaceuticals--
VIRIVirios Therapeutics--
ENVBEnveric Biosciences--
EFTReFFECTOR Therapeutics--

BIOR Revenue FAQ

What is Biora Therapeutics’s yearly revenue?

Biora Therapeutics's yearly revenue for 2023 was $4K, representing a decrease of -98.69% compared to 2022. The company's yearly revenue for 2022 was $305K, representing a decrease of -75.54% compared to 2021. BIOR's yearly revenue for 2021 was $1.25M, representing a decrease of -98.32% compared to 2020.

What is Biora Therapeutics’s quarterly revenue?

Biora Therapeutics's quarterly revenue for Q3 2024 was $32K, a -89.94% decrease from the previous quarter (Q2 2024), and a 0% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $318K, a -41.33% decrease from the previous quarter (Q1 2024), and a 15800.00% increase year-over-year (Q2 2023). BIOR's quarterly revenue for Q1 2024 was $542K, a -37.84% decrease from the previous quarter (Q4 2023), and a 27000.00% increase year-over-year (Q1 2023).

What is Biora Therapeutics’s revenue growth rate?

Biora Therapeutics's revenue growth rate for the last 3 years (2021-2023) was -99.68%, and for the last 5 years (2019-2023) was -100.00%.

What are Biora Therapeutics’s revenue streams?

Biora Therapeutics's revenue streams in c 21 are Commercial Third Party Payors, Patient Laboratory Distribution Partners, and Government Health Benefit Programs. Commercial Third Party Payors generated $42.1M in revenue, accounting 69.46% of the company's total revenue, down -34.66% year-over-year. Patient Laboratory Distribution Partners generated $4.42M in revenue, accounting 7.30% of the company's total revenue, down -38.12% year-over-year. Government Health Benefit Programs generated $14.08M in revenue, accounting 23.24% of the company's total revenue, up 415.75% year-over-year.

What is Biora Therapeutics’s main source of revenue?

For the fiscal year ending Dec 21, the largest source of revenue of Biora Therapeutics was Commercial Third Party Payors. This segment made a revenue of $42.1M, representing 69.46% of the company's total revenue.